Essential Medicines List (EML) 2021 Application for the inclusion of delamanid 25 mg dispersible tablet in the Complementary Lis
Frontiers | Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment | Molecular Pharmaceutics
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in ...
US pressure could make UN TB declaration less forceful, MSF says | Devex
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis | eLife
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial | Antimicrobial Agents and Chemotherapy
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects | Antimicrobial Agents and Chemotherapy
Delamanid - an overview | ScienceDirect Topics
Microorganisms | Free Full-Text | Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
DR-TB Drugs Under the Microscope, 4th edition, March 2016 by Médecins Sans Frontières (MSF) International - Issuu
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis | European Respiratory Society
Frontiers | Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
Deltyba 50 Mg Delamanid, Packaging Size: 48
Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers - Zou - British Journal of Clinical Pharmacology - Wiley Online Library
Delamanid
DR-TB Treatment Webinar Deck_Final
TB drug delamanid must be more affordable and made available in more countries
Efficacy results of Otsuka's delamanid (Deltyba™) for XDR-TB published in the New England Journal of Medicine
Fraction of TB patients getting most effective drugs, but pharma companies stress access efforts
Delamanid MDR/PRE XDR/XDR मरीजों के लिए टीबी की नई दवा।क्या हैं डोज। लेने का सही तरीका।देखें वीडियो - YouTube
Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval | Médecins Sans Frontières Access Campaign
Anti-TB drug Delamanid fast drying out, Centre yet to receive new stocks from Japan - The Hindu BusinessLine
Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers - Zou - British Journal of Clinical Pharmacology - Wiley Online Library
Drug-resistant TB: “Some of our patients simply can't wait for clinical trials” | Médecins Sans Frontières Luxembourg
Bedaquiline, Delamanid cut treatment time for drug-resistant TB | Nagpur News - Times of India
These are the dimensions presentation slides must be in for Scientific Day 2014
DELTYBA tablets 50mg(Delamanid) by Otsuka Pharmaceutical Co., Ltd., formed registered in Japan | synapse
